Combining imaging mass spectrometry and immunohistochemistry to analyse the lipidome of spinal cord inflammation

Anal Bioanal Chem. 2024 Mar;416(8):1923-1933. doi: 10.1007/s00216-024-05190-3. Epub 2024 Feb 7.

Abstract

Inflammation is a complex process that accompanies many pathologies. Actually, dysregulation of the inflammatory process is behind many autoimmune diseases. Thus, treatment of such pathologies may benefit from in-depth knowledge of the metabolic changes associated with inflammation. Here, we developed a strategy to characterize the lipid fingerprint of inflammation in a mouse model of spinal cord injury. Using lipid imaging mass spectrometry (LIMS), we scanned spinal cord sections from nine animals injected with lysophosphatidylcholine, a chemical model of demyelination. The lesions were demonstrated to be highly heterogeneous, and therefore, comparison with immunofluorescence experiments carried out in the same section scanned by LIMS was required to accurately identify the morphology of the lesion. Following this protocol, three main areas were defined: the lesion core, the peri-lesion, which is the front of the lesion and is rich in infiltrating cells, and the uninvolved tissue. Segmentation of the LIMS experiments allowed us to isolate the lipid fingerprint of each area in a precise way, as demonstrated by the analysis using classification models. A clear difference in lipid signature was observed between the lesion front and the epicentre, where the damage was maximized. This study is a first step to unravel the changes in the lipidome associated with inflammation in the context of diverse pathologies, such as multiple sclerosis.

Keywords: Imaging mass spectrometry; Immunohistochemistry; Inflammation; Lipidomics.

MeSH terms

  • Animals
  • Immunohistochemistry
  • Inflammation
  • Lipidomics*
  • Lipids
  • Mass Spectrometry
  • Mice
  • Myelitis*

Substances

  • Lipids